| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 416.2 | 384.2 |
| Gross profit | 200.6 | 186.4 |
| Profit before tax | 55.8 | 38.5 |
| Net income | 42.3 | 27.8 |
| EPS (diluted, $ a share) | $0.70 | $0.46 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | +52.4% |
|---|---|
| Revenue, year on year | +8.4% |
| Gross margin | 48.2% |
| Operating margin | 14.1% |
10-Q filed with the SEC, NASDAQ: MMSI. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Merit Medical Systems Inc: key numbers
- Share price
- $84.49Close, Nov 17
- Market cap
- $5.06B
- Shares outstanding
- 59.92MLatest SEC cover page
- Sector
- Industrial Applications and Services
- Industry
- Surgical & Medical Instruments & ApparatusSIC 3841
Today's reference numbers, updated daily. Not a valuation or a recommendation.
More from Merit Medical Systems Inc
All →Merit Medical Systems CLO, Secretary Brian G. Lloyd Sells $1.44M of Stock
Brian G. Lloyd, CLO, Secretary, sold 16,722 shares of Merit Medical Systems Inc at $86.33 a share, worth $1.44M in total on Nov 16, 2026. Shares held after the trade: 60,132 (-21.8%).
- Value
- $1.44M
- Shares
- 16,722
- Price
- $86.33
- Role
- CLO, Secretary
- Holding change
- -21.8%
- Trade date
- Nov 16, 2026
Merit Medical Systems Earnings Call: Key Takeaways
Merit Medical delivered a strong Q3 2026 beat, raising full-year guidance driven by 9% organic growth and significant operating margin expansion despite gross margin headwinds.
Merit Medical Systems Financial Results
Merit Medical Systems reported Q3 2026 financial results with 8.4% revenue growth and raised its full-year 2026 guidance. The company also disclosed the $45 million cash acquisition of Solo Pace, Inc., which was completed on October 13, 2026.
- Counterparty
- Solo Pace, Inc.
“Merit delivered third quarter financial results that exceeded the high end of our expectations, driven primarily by 9% organic, constant currency revenue growth, excluding the impact of a strategic divestiture.”
Martha G. Aronson, Merit’s President and CEO
“We have raised our 2026 revenue and non-GAAP earnings per share guidance to reflect the stronger-than-expected results over the first nine months of 2026 and remain confident in our team’s ability to execute, with attractive constant currency growth, improving profitability, and solid cash flow generation this year.”
Martha G. Aronson, Merit’s President and CEO